The Centre for Menstrual Cycle and Ovulation Research (CeMCOR)

Dr. Jerilynn Prior - CeMCOR
The UBC Centre for Menstrual Cycle and Ovulation Research (CeMCOR) is the only centre worldwide dedicated to understanding how regularly ovulating and making progesterone affects women’s lifelong health. While the factors that regulate ovulation are important for reproductive health, they also directly influence bone growth, heart health and cancer risk. CeMCOR focuses on holistic health for women of all ages. Current projects at the centre include approaches to dealing with brittle bones, cancer prevention, treating hot flushes, fertility, cardiometabolic health and healthy aging. You can support the work of the centre by  making a donation.

Through clinical research, the centre’s investigators provide innovative, practical information to health care providers and women of all ages. They value women’s self-knowledge about their bodies and experiences. In addition, the re-designed CeMCOR website is a popular resource for women of all ages and garners 3,800 to 5,000 page views per day from close to 200 countries around the world. CeMCOR’s research is not-for-profit, which ensures that its work focuses on improving evidence-based health care for women.

Since its founding in 2002 by Scientific Director Dr. Jerilynn Prior, CeMCOR has achieved many milestones in women’s health. Researchers at the centre have:

  • found a safer, more effective treatment for disruptive menopausal hot flushes;
  • worked with Norwegian scientists in a population-wide study to show that ovulation may be silently absent in one third of regular cycles;
  • documented that progesterone increases free thyroid hormone and helps decrease cardiac risk factors; and
  • shown a strong link between young women who do not consistently ovulate and loss of bone mineral density.

Recently, CeMCOR gained a new Scientific Co-Director, Dr. Shirin Kalyan, who brings a unique ability to unite seemingly disparate aspects of physiology in a holistic view; she is linking stress, immune function, and reproduction to women’s health outcomes. Dr. Kalyan’s work will shed light on how to best manage chronic inflammatory disorders and autoimmune diseases (such as rheumatoid arthritis and lupus), which primarily affect women.

CeMCOR’s website, women’s support services and most daily operating expenses are funded by philanthropic support from generous donors like you. Your support is urgently needed to continue advances in CeMCOR’s innovative research that is improving health outcomes for women in our families, communities and worldwide.